EDOG - Institut Claudius Regaud - PPDS

Toulouse 31100

0 studies enrolling now · 6 studies all time

What they study most

AML Arising From Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Colorectal Cancer, Cytomegalovirus (CMV), Leukemia, Myeloid, Acute, Locally Recurrent Breast Cancer, Lymphoma, B-Cell, Metastatic Breast Cancer, Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML

Studies at this site

• Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation — Running, not enrolling
• A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy — Completed
• Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer — Stopped early
• A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants — Completed
• Study to Evaluate Tolerability of Iberdomide (CC-220) in Combination With Polatuzumab Vedotin Plus Rituximab or Tafasitamab or Rituximab Plus Chemotherapy in B-cell Lymphoma — Withdrawn before enrolling
• Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer — Completed